Nankai Chemical Co Ltd

Nankai Chemical Co Ltd maintains a capital structure with a debt-to-equity ratio of 0.67, indicating a moderate reliance on debt financing. The company's liquidity position is assessed as medium, with a current ratio of 0.97, suggesting that its current liabilities slightly exceed its current assets. The company's price-to-book ratio is 0.73, and its price-to-tangible-book ratio is also 0.73, indicating that the market values the company's tangible assets at a discount relative to its book value. In terms of profitability, Nankai Chemical Co Ltd reports a return on equity (ROE) of 12.1% and a return on assets (ROA) of 4.52%. These figures are below the industry median for ROE and ROA in the Diversified Chemicals sector, suggesting that the company is underperforming its peers in terms of capital efficiency and asset utilization. The company's revenue is derived from two primary segments: the chemical business and the various salts business. The chemical business segment is engaged in the manufacture and sale of chlor-alkali products, food additives, and other chemical products. The various salts business segment is engaged in the manufacture and sale of various salts. The company's geographic exposure is primarily concentrated in Japan, with no significant international operations disclosed in the available data. Nankai Chemical Co Ltd's growth trajectory is modest, with the company's outlook for the current fiscal year indicating a slight increase in revenue. The company's capital expenditure for the latest period was negative at -2,043,000,000 JPY, suggesting a reduction in investment in new assets. The company's free cash flow is also low at 25,000,000 JPY, indicating limited capacity for reinvestment or shareholder returns. The company's risk assessment highlights a medium liquidity risk, with a key flag indicating that net cash is negative after subtracting total debt. The dilution risk is assessed as low, with no significant dilution potential identified in the basic shares outstanding. The company's risk profile is further influenced by its moderate debt levels and limited international diversification. Recent events and disclosures include the company's 2023 annual report, which provides details on its financial performance and strategic direction. The report indicates that the company is focused on maintaining its core chemical business while exploring opportunities for growth in related markets. No significant regulatory or geopolitical risks are disclosed in the latest filings, although the company's exposure to the Japanese market may limit its resilience to regional economic fluctuations.